These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 38698328)

  • 1. Evaluation of the exit screening policy among travelers arriving from Asian and pacific nations.
    Liu S; Anzai A; Nishiura H
    BMC Infect Dis; 2024 May; 24(1):464. PubMed ID: 38698328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing exit screening of SARS-CoV-2 in Japan: an analysis of the airport screening data of passengers from the United Kingdom, 2020-2022.
    Liu S; Anzai A; Nishiura H
    BMC Infect Dis; 2024 Sep; 24(1):962. PubMed ID: 39267012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Travel-related control measures to contain the COVID-19 pandemic: a rapid review.
    Burns J; Movsisyan A; Stratil JM; Coenen M; Emmert-Fees KM; Geffert K; Hoffmann S; Horstick O; Laxy M; Pfadenhauer LM; von Philipsborn P; Sell K; Voss S; Rehfuess E
    Cochrane Database Syst Rev; 2020 Oct; 10():CD013717. PubMed ID: 33502002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiology and Risk of Coronavirus Disease 2019 Among Travelers at Airport and Port Quarantine Stations Across Japan: A Nationwide Descriptive Analysis and an Individually Matched Case-Control Study.
    Tsuboi M; Hachiya M; Ohtsu H; Akashi H; Miyoshi C; Umeda T
    Clin Infect Dis; 2022 May; 74(9):1614-1622. PubMed ID: 34318872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. International travel-related control measures to contain the COVID-19 pandemic: a rapid review.
    Burns J; Movsisyan A; Stratil JM; Biallas RL; Coenen M; Emmert-Fees KM; Geffert K; Hoffmann S; Horstick O; Laxy M; Klinger C; Kratzer S; Litwin T; Norris S; Pfadenhauer LM; von Philipsborn P; Sell K; Stadelmaier J; Verboom B; Voss S; Wabnitz K; Rehfuess E
    Cochrane Database Syst Rev; 2021 Mar; 3(3):CD013717. PubMed ID: 33763851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Universal screening for SARS-CoV-2 infection: a rapid review.
    Viswanathan M; Kahwati L; Jahn B; Giger K; Dobrescu AI; Hill C; Klerings I; Meixner J; Persad E; Teufer B; Gartlehner G
    Cochrane Database Syst Rev; 2020 Sep; 9(9):CD013718. PubMed ID: 33502003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Public health effects of travel-related policies on the COVID-19 pandemic: A mixed-methods systematic review.
    Bou-Karroum L; Khabsa J; Jabbour M; Hilal N; Haidar Z; Abi Khalil P; Khalek RA; Assaf J; Honein-AbouHaidar G; Samra CA; Hneiny L; Al-Awlaqi S; Hanefeld J; El-Jardali F; Akl EA; El Bcheraoui C
    J Infect; 2021 Oct; 83(4):413-423. PubMed ID: 34314737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk Assessment and Management of COVID-19 Among Travelers Arriving at Designated U.S. Airports, January 17-September 13, 2020.
    Dollard P; Griffin I; Berro A; Cohen NJ; Singler K; Haber Y; de la Motte Hurst C; Stolp A; Atti S; Hausman L; Shockey CE; Roohi S; Brown CM; Rotz LD; Cetron MS; ; Alvarado-Ramy F
    MMWR Morb Mortal Wkly Rep; 2020 Nov; 69(45):1681-1685. PubMed ID: 33180758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reconstructing the COVID-19 incidence in India using airport screening data in Japan.
    Liu S; Anzai A; Nishiura H
    BMC Infect Dis; 2024 Jan; 24(1):12. PubMed ID: 38166666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exit and Entry Screening Practices for Infectious Diseases among Travelers at Points of Entry: Looking for Evidence on Public Health Impact.
    Mouchtouri VA; Christoforidou EP; An der Heiden M; Menel Lemos C; Fanos M; Rexroth U; Grote U; Belfroid E; Swaan C; Hadjichristodoulou C
    Int J Environ Res Public Health; 2019 Nov; 16(23):. PubMed ID: 31766548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of international travel dynamics on domestic spread of 2019-nCoV in India: origin-based risk assessment in importation of infected travelers.
    Gunthe SS; Patra SS
    Global Health; 2020 May; 16(1):45. PubMed ID: 32398137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Symptoms and Characteristics Which Require Attention During COVID-19 Screening at a Port of Entry.
    Song SW; Kim D; Park JY; Lee S
    J Korean Med Sci; 2021 Jan; 36(2):e14. PubMed ID: 33429473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence of COVID-19 among returning travelers in quarantine facilities: A longitudinal study and lessons learned.
    Al-Tawfiq JA; Sattar A; Al-Khadra H; Al-Qahtani S; Al-Mulhim M; Al-Omoush O; Kheir HO
    Travel Med Infect Dis; 2020; 38():101901. PubMed ID: 33049360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reducing travel-related SARS-CoV-2 transmission with layered mitigation measures: symptom monitoring, quarantine, and testing.
    Johansson MA; Wolford H; Paul P; Diaz PS; Chen TH; Brown CM; Cetron MS; Alvarado-Ramy F
    BMC Med; 2021 Apr; 19(1):94. PubMed ID: 33849546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SARS-CoV-2 Wave Two Surveillance in East Asia and the Pacific: Longitudinal Trend Analysis.
    Post LA; Lin JS; Moss CB; Murphy RL; Ison MG; Achenbach CJ; Resnick D; Singh LN; White J; Boctor MJ; Welch SB; Oehmke JF
    J Med Internet Res; 2021 Feb; 23(2):e25454. PubMed ID: 33464207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modelling the effect of travel-related policies on disease control in a meta-population structure.
    Xu J; Wang Z; Moghadas SM
    J Math Biol; 2023 Sep; 87(4):55. PubMed ID: 37688625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monitoring International Travelers Arriving in Hong Kong for Genomic Surveillance of SARS-CoV-2.
    Gu H; Cheng SSM; Krishnan P; Ng DYM; Chang LDJ; Liu GYZ; Cheuk SSY; Hui MMY; Fan MCY; Wan JHL; Lau LHK; Chu DKW; Dhanasekaran V; Peiris M; Poon LLM
    Emerg Infect Dis; 2022 Jan; 28(1):247-250. PubMed ID: 34932453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccine effectiveness against SARS-CoV-2 reinfection during periods of Alpha, Delta, or Omicron dominance: A Danish nationwide study.
    Nielsen KF; Moustsen-Helms IR; Schelde AB; Gram MA; Emborg HD; Nielsen J; Hansen CH; Andersen MA; Meaidi M; Wohlfahrt J; Valentiner-Branth P
    PLoS Med; 2022 Nov; 19(11):e1004037. PubMed ID: 36413551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Travelers' risk of malaria by destination country: a study from Japan.
    Tada Y; Okabe N; Kimura M
    Travel Med Infect Dis; 2008 Nov; 6(6):368-72. PubMed ID: 18984482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Self-collection and pooling of samples as resources-saving strategies for RT-PCR-based SARS-CoV-2 surveillance, the example of travelers in French Polynesia.
    Aubry M; Teiti I; Teissier A; Richard V; Mariteragi-Helle T; Chung K; Deen F; Paoaafaite T; Cao-Lormeau VM
    PLoS One; 2021; 16(9):e0256877. PubMed ID: 34473769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.